TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Clinical trial NCT06353360 · UNKNOWN
Trial details
- NCT number
- NCT06353360
- Sponsor
- Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2025-07-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.